Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01818531 · ClinicalTrials.gov registry record · Phase 4

Adductor Canal Block for Medial Compartment Knee Arthroplasty

A Phase 4 study of Postoperative Analgesia and Medial Unicompartmental Knee Arthroplasty, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
Phase 4
Development phase
150
Enrollment target
1
Study location

NCT01818531 is a Phase 4 study of Postoperative Analgesia and Medial Unicompartmental Knee Arthroplasty that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01818531, a Phase 4 study of Postoperative Analgesia and Medial Unicompartmental Knee Arthroplasty, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
Phase 4
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the affects of a single injection ultrasound-guided adductor canal block for patients undergoing robotic-assisted (MAKOplasty) medial UKA (unicompartmental knee arthroplasty). Specifically, this study will compare the adequacy of postoperative analgesia provided by the adductor canal block with that provided by single injection lumbar plexus blockade. The working hypothesis is that the analgesia provided by the adductor canal block will be equivalent to the analgesia provided by the lumbar plexus block. The primary outcome will be a comparison of verbal numerical pain scores at rest and with movement over the first 24 hours following nerve blockade.

Interventions

  • DRUG Adductor canal block
  • DRUG Lumbar plexus block

Study Locations (1)

North Carolina

  • Wake Forest University Baptist Medical Center - Winston-Salem

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2013-04
Est. Completion 2015-05
Phase Phase 4

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT01818531

The ClinicalTrials.gov registry entry for NCT01818531 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Postoperative Analgesia appearing as the primary indexed condition, and to 2 interventions - of which Adductor canal block is the first listed.

NCT01818531 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01818531 about?

NCT01818531 is a clinical study titled "Adductor Canal Block for Medial Compartment Knee Arthroplasty". This study will evaluate the affects of a single injection ultrasound-guided adductor canal block for patients undergoing robotic-assisted (MAKOplasty) medial UKA (unicompartmental knee arthroplasty). Specifically, this study will compare the adequacy of postoperative analgesia provided by the adduc...

What is the current status of trial NCT01818531?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2013-04. Estimated completion is 2015-05.

What conditions does trial NCT01818531 study?

This clinical trial studies the following conditions: Postoperative Analgesia, Medial Unicompartmental Knee Arthroplasty.

What interventions are being tested in trial NCT01818531?

The interventions under investigation include: Adductor canal block (DRUG), Lumbar plexus block (DRUG).

Who is sponsoring clinical trial NCT01818531?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01818531 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.